These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Comparative effectiveness of flupenthixol and risperidone on negative symptoms of schizophrenia].
    Author: Philipp M, Lesch OM, Schmauss M, Dose M, Glaser T.
    Journal: Psychiatr Prax; 2003 May; 30 Suppl 2():S94-6. PubMed ID: 14509050.
    Abstract:
    The efficacy of flupentixol and risperidone were compared in a randomized double-blind study in 153 chronic schizophrenic patients. Flupentixol showed to be not inferior to risperidone concerning schizophrenic negative symptoms at week 8, 16 and 24. Positive symptoms and general psychopathology improved comparably, too. There was a trend in favor of flupentixol concerning the improvement of depressive symptoms and a trend in favor of risperidone concerning the improvement of preexisting parkinsonian symptoms. The study data justify to regard flupentixol as a "partial atypical" antipsychotic.
    [Abstract] [Full Text] [Related] [New Search]